ARTICLE SUMMARY:
March's most-read articles: Edwards Lifesciences exec roundtable, 20 diabetes companies to watch, Magnus Medical's depression treatment, the diagnostics industry post-COVID, and Alva Health's wearable stroke monitor.
The top five MedTech Strategist March articles.
Subscribers, click through to read the full articles. Non-subscribers, take advantage of our free trial offer.
#1: Edwards Lifesciences: 20 Years After
After its spin-off from Baxter in 2000, Edwards’ strategy was more “Don’t make waves” than “Shake things up.” But the promise of transcatheter valve replacement was too great and now, two decades after the launch of its TAVR program, Edwards stands atop the cardiovascular device industry. A roundtable discussion with Mike Mussallem, Larry Wood, and Bernard Zovighian.
#2: Diabetes Market on the Upswing: 20 Companies to Watch in 2022
Technology advances in diabetes continue unabated despite pandemic-related pressures, and several companies have achieved important milestones over the past several months. Here, we summarize current market and technology trends for continuous glucose monitoring, insulin pumps, and stem-cell therapy and highlight 20 companies to watch in 2022 and beyond.
#3: Devices for Depression Aim for a Network Effect
In-clinic TMS has established itself as a safe, but only moderately effective therapy for treatment-resistant depression. To help the most critically ill depression patients, Magnus Medical looks like it has figured out how to boost both the speed and efficacy of TMS by targeting brain structures able to generate a network effect. Will it open the door to other markets in depression and mental health?
#4: The Diagnostics Industry Moves Beyond COVID-19
Backed by government funding and huge unmet needs, COVID-19 has been an innovation and financial windfall for many diagnostics companies. The influx of resources will have post-pandemic ramifications for rapid and at-home testing, sample collection, and industry structure. An interview with Quanterix’s Kevin Hrusovsky.
#5: Alva Health: Wearable Stroke Monitor Offers 24/7 Early Warning System
Alva Health, winner of the 2021 MedTech Innovator Global Competition, is developing a unique wearable system capable of remotely monitoring high-risk patients for stroke or TIA. The system operates around the clock, even while the wearer is asleep, and automatically sends alerts when something is amiss.
Trial MyStrategist.com and unlock 7-days of exclusive subscriber-only access to the medical device industry's most trusted strategic publications: MedTech Strategist & Market Pathways. For more information on our demographics and current readership click here.